Vitamin C is synthesized internally by most living things. Humans are among a very small number of living things that must instead supplement it through their diets by eating fruits, vegetables and plants that contain small amounts of it.
High doses of intravenous Vitamin C, clinically known as intravenous ascorbic acid (or IAA), is now one of the most popular supportive treatments used for cancer despite conservative sentiments within mainstream oncology.
Naturopathic medicine has long held IV Vitamin C as a valuable additional treatment, and thanks largely to the work of Dr Linus Pauling – winner of both the Nobel Prize for Chemistry and the Nobel Peace Prize – and others since the 1970s, the body of supporting clinical evidence has been steadily growing.
High doses of intravenous vitamin C have been shown to be selectively toxic to cancer cells, breaking down and destroying tumors while simultaneously supporting and boosting the body’s natural immune functions. But because of specific differences between how cancerous cells and healthy cells metabolize vitamin C, normal cells benefit highly from its presence, while it produces toxins within cancerous cells, eventually killing them.
Most forms of cancer have been tested against with positive effects being indicated in many cases. Clinical tests have shown a range of positive results, using dosages anywhere from 10 – 100 mg, and injections being administered from 2 to 7 days per week. Testing times have ranged from short term supplemental treatment lasting several weeks, to ongoing supplementation lasting many years.
Intravenous vitamin C is always accompanied by other treatments, and is regarded by proponents as a highly valuable supplemental treatment that can improve patients’ quality of life while also aiding in tumor treatment.
As with all medicinal treatments, naturopathic or otherwise, careful monitoring by an attending physician is vital to both the health and wellbeing of the patient, and the success of the treatment.